NEW YORK, Sept. 8, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Global High Throughput Screening (HTS) Industry
http://www.reportlinker.com/p0611062/Global-High-Throughput-Screening-HTS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc
This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 103 companies including many key and niche players such as Agilent Technologies Inc., BIOCIUS Life Sciences, Inc, Aurora Biomed Inc., Axxam SpA, Beckman Coulter, Inc., BioFocus DPI Ltd., Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Caliper Life Sciences, Inc., Corning Inc., DiscoveRx Corporation, EVOTEC BioSystems, ForteBio, Inc., Genedata AG, IntelliCyt Corporation, Life Technologies Corporation, Luminex Corporation, Molecular Devices Inc., PerkinElmer Inc., Roche Applied Sciences, Sigma-Aldrich Corporation, and Tecan Group Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
2. INDUSTRY OVERVIEW 4
A Prelude 4
Current and Future Analysis 4
Market Scenario 4
How Far Has HTS Been Successful - A Case For and Against HTS 6
Market Share Findings 7
Table 1: World Liquid Handling Market (2010): Percentage
Market Share Breakdown of Leading Players (includes
corresponding Graph/Chart) 7
Table 2: World Robotics Market (2010): Percentage Market
Share Breakdown of Leading Players (includes corresponding
Graph/Chart) 8
Table 3: World Microplate Readers Market (2010): Percentage
Market Share Breakdown of Leading Players (includes
corresponding Graph/Chart) 8
3. MARKET TRENDS & ISSUES 9
HTS Adapts to Varied Lead Discovery Needs 9
Compound Library and Target Selection Equally Important as
Screening 9
Cell-based Assays Represent the Primary Drug Discovery Tool in
HTS Labs 9
Smaller Companies and Academia Can Now Afford HTS 9
Innovation in Screening Guarantees Success for Drug Discovery
Programs 10
HTS Advancements Promise a Bright Future for Stem Cell Research 10
HTS in the Discovery of Drug for Alzheimer's Disease 11
Need for Stringent QA System to Keep Failures at Bay 11
HTS Used in Identification of Kinase Inhibitors 12
4. HTS TECHNOLOGY OVERVIEW 13
What Drives HTS Labs Towards New Technologies 13
Major HTS Technologies 13
Miniaturization 13
HTS Miniaturization - Technology Developments 14
IVC - A Miniaturized, Powerful HTS Technology 14
Target Selection 14
Label-free Technologies 15
High-Content Screening (HCS) 15
Innovations in Cell Culture 15
Compound Libraries Expansion 16
HTS - A Historical Perspective 16
5. PRODUCT OVERVIEW 18
High Throughput Research (HTR) 18
High Throughput - An Advanced Materials Research Approach 18
Pharmaceutical Industry Leads the Way 18
High Throughput Improves R&D Efficiency 19
High Throughput Screening (HTS) 19
The Equipment 19
The Process 20
HTS Robotics Supports Miniaturization 21
HTS and uHTS 21
Functional and Non-Functional - Two Types of High Throughput
Assays 21
Setting up HTS Facilities - An Expensive Affair 21
Important Components of HTS 22
Few popular Chemical Libraries Used in Chemical Biology and
Drug Discovery 22
Table 4: Screening Throughput of Plates (includes
corresponding Graph/Chart) 22
Distinctions Between Bench Top and HTS Assays 23
6. HTS AND THE PHARMA INDUSTRY 24
Impact of HTS on the Pharmaceutical Industry 24
The Underlying Technology and Market Factors 24
High Costs Involved with Sophistication - A Matter of Concern 24
The HTS Business in Pharma Industry 25
What Lies Ahead for HTS 25
Hit and Lead Generation Strategies 26
Different Stages in Hit and Lead Generation 26
From 'Hit' to 'Lead' in HTS - A Complex Endeavor 26
7. DRUG DISCOVERY - AN OVERVIEW 28
Drug Discovery - Definition 28
Drug Discovery Process 28
Drug Discovery Technologies 28
8. COMPUTER AIDED DRUG DISCOVERY (CADD) 30
The Evolution of Computer Aided Drug Discovery (CADD) Processes 30
CADD 30
High Throughput Screening 30
Virtual Screening 31
Cloud Computing 31
9. PRODUCT INNOVATIONS/INTRODUCTIONS 32
Tox21 Launches Novel Robotic High Speed Screening System 32
Life Technologies Introduces TaqMan OpenArray MicroRNA Panels 32
Zyleris Introduces Screening Service for Drug Development 32
Genosphere Introduces PepLib™ Custom Peptide Library Synthesis 33
PerkinElmer Launches Lance Ultra cAMP Detection Kit for
Profiling GPCRs 33
PerkinElmer Introduces Epigenetics Detection Reagents for HTS
of New Drug Candidates 33
Agilent and BIOCIUS Introduce RF360 High Resolution System 33
High Throughput Genomics and Luminex Introduce qBead Assay 34
IntelliCyt Launches HTFCTM Screening System 34
Luminex Corporation Launches FLEXMAP 3D, a High-Throughput System 34
ForteBio Introduces Advanced Instruments for Life Science
Research Industry 35
BioTrove Introduces RapidFire® 300 System for HTS of ADME Assays 35
Sigma-Aldrich Launches PrecisioTM Kinases for High Througput
Profiling 36
Genedata Launches Genedata Screener 7.0 for HCS and HTS Analysis 36
Roche Diagnostics Introduces RTCA HT Instrument 36
Axxam and CyBio Introduce An Advanced Screening Station 37
BMG LABTECH Unveils PHERAstar FS Reader for HTS Applications 37
PharmaDiagnostics Unveils SoPRano CA1 Assay Kit 37
SwitchGear Genomics Introduces High Throughput Screening Tools 38
PerkinElmer Launches Upgraded MicroBeta®2 Microplate Counter
Platform 38
Intellicyt Launches Hypercyt Based Application, Flowtox Screening 38
10. RECENT INDUSTRY ACTIVITY 39
Agilent Technologies Takes Over BIOCIUS Life Sciences 39
EVOTEC BioSystems Takes Over Kinaxo Biotech 39
Beckman Coulter and Vitrology Ink Biologics Testing
Partnership Agreement 39
Sigma Life Sciences and King's College Co-develop Target
Identification Technology 40
Lundbeck and Compound Focus Ink Compound Management Agreement 40
Ligand to Divest Combinatorial Library and Certain
Technologies to Venenum 40
DiscoveRx Corp Acquires Kinase Screening Service Division of
Ambit Biosciences 40
Omeros Takes Over GPCR Assay Technology from Patabios 41
TGS Collaborates with CarnaBio for Providing Drug Discovery
Services 41
AstraZeneca and MRC Technology Team Up for Drug Discovery,
Share Compound Libraries 41
Evotec and Biotech Partner for Small Molecule Modulator
Identification 42
ForteBio and Tecan Team Up to Provide Automated Label-Free Assays 42
Protein Attachment and Blue Sky Biotech Ink Licensing Agreement 42
BioAtla and Halozyme Team Up 42
Jubilant Biosys and DiscoveRx Enter into an Co-marketing
Agreement 43
Plasticell Inks Partnership Agreement with Sigma-Aldrich 43
Redpoint Bio Receives US Patent for its HTS Assay for TRPm5
Ion Channel 43
Corning Takes Over Axygen BioScience 44
ChanTest Takes over Applied Cell Sciences 44
Nexus Biosystems Takes over Aurora Biotechnologies 44
PerkinElmer Acquires Assets of GE Healthcare 45
Cellectis and Laboratoires Servier Ink Licensing Agreement 45
BioFocus to Integrate TET Technology in HTS Services 45
BioFocus DPI Upgrades High-Throughput Screening Library 45
Ono Pharmaceutical and Evotec Extend Research Collaboration 45
Randox Labs and Seegene Enter into Agreement 46
BioFocus DPI and Cellectricon Enter into Collaboration 46
Evotec and DiscoveRx Ink Agreement to Support HTS Services 46
Corning Announces a Major Milestone in Label- Free High
Throughput Screening 47
11. FOCUS ON SELECT GLOBAL PLAYERS 48
Agilent Technologies Inc. (US) 48
BIOCIUS Life Sciences, Inc. (US) 48
Aurora Biomed Inc. (Canada) 49
Axxam SpA (Italy) 49
Beckman Coulter, Inc (US) 49
BioFocus DPI Ltd (UK) 50
Bio-Rad Laboratories, Inc. (US) 50
BMG LABTECH GmbH (Germany) 51
Caliper Life Sciences, Inc (US) 51
Corning Inc (US) 52
DiscoveRx Corporation (US) 52
EVOTEC BioSystems (Germany) 53
ForteBio, Inc (US) 53
Genedata AG (Switzerland) 53
IntelliCyt Corporation (US) 53
Life Technologies Corporation (US) 54
Luminex Corporation (US) 54
Molecular Devices Inc. (US) 54
PerkinElmer Inc (US) 55
Roche Applied Sciences (Germany) 56
Sigma-Aldrich Corporation (US) 56
Tecan Group Ltd. (Switzerland) 56
12. GLOBAL MARKET PERSPECTIVE 58
Table 5: World Recent Past, Current & Future Analysis for High
Throughput Screening by Geographic Region - US, Canada, Japan,
Europe and Rest of World Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) 58
Table 6: World Historic Review for High Throughput Screening
by Geographic Region - US, Canada, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Revenues in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 59
Table 7: World 15-Year Perspective for High Throughput
Screening by Geographic Region - Percentage Breakdown of
Dollar Revenues for US, Japan, Europe, and Rest of World
Markets for Years 2003, 2010 & 2017 (includes corresponding
Graph/Chart) 60
13. THE UNITED STATES 61
A.Market Analysis 61
Outlook 61
Factors Driving Growth in the US HTS Market 61
Government Providing a Helping Hand 61
Product Introductions 62
Recent Industry Activity 65
Key Players 68
B.Market Analytics 76
Table 8: US Recent Past, Current & Future Analysis for High
Throughput Screening Market Independently Analyzed with
Annual Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) 76
Table 9: US Historic Review for High Throughput Screening
Market Independently Analyzed with Annual Revenues in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) 76
14. CANADA 77
A.Market Analysis 77
Outlook 77
Key Players 77
B.Market Analytics 78
Table 10: Canadian Recent Past, Current & Future Analysis
for High Throughput Screening Market Independently Analyzed
with Annual Revenues in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) 78
Table 11: Canadian Historic Review for High Throughput
Screening Market Independently Analyzed with Annual Revenues
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 78
15. JAPAN 79
A.Market Analysis 79
Outlook 79
Recent Industry Activity 79
B.Market Analytics 80
Table 12: Japanese Recent Past, Current & Future Analysis
for High Throughput Screening Market Independently Analyzed
with Annual Revenues in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) 80
Table 13: Japanese Historic Review for High Throughput
Screening Market Independently Analyzed with Annual Revenues
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 80
16. EUROPE 81
A.Market Analysis 81
Outlook 81
Market Shifts Towards Maturity - Technological Innovations
Come to the Rescue 81
Product Introductions 81
Recent Industry Activity 83
Key Players 85
B.Market Analytics 88
Table 14: European Recent Past, Current & Future Analysis
for High Throughput Screening Market Independently Analyzed
with Annual Revenues in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) 88
Table 15: European Historic Review for High Throughput
Screening Market Independently Analyzed with Annual Revenues
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 89
17. REST OF WORLD 90
A.Market Analysis 90
Outlook 90
Regional Overview 90
HTS Gaining Ground in APAC 90
China 90
China Emerges as the Major Outsourcer for Drug Discovery 90
Few Problem Areas Exist 91
What Outsourcers Need to Look Forward to 91
Life Sciences Market in China Continues to Thrive Despite
Recession 91
B.Market Analytics 92
Table 16: Rest of World Recent Past, Current & Future
Analysis for High Throughput Screening Market Independently
Analyzed with Annual Revenues in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) 92
Table 17: Rest of World Historic Review for High Throughput
Screening Market Independently Analyzed with Annual Revenues
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) 92
COMPETITIVE LANDSCAPE
Total Companies Profiled: 103 (including Divisions/Subsidiaries - 106)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 64
Canada 1
Japan 2
Europe 35
France 4
Germany 10
The United Kingdom 12
Italy 1
Rest of Europe 8
Asia-Pacific (Excluding Japan) 4
------------------------------------------
To order this report:
Drug Discovery and Development Industry: Global High Throughput Screening (HTS) Industry
Drug Discovery and Development Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article